Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy

  • Authors:
    • Shimpei Nishikawa
    • Masamitsu Konno
    • Atsushi Hamabe
    • Shinichiro Hasegawa
    • Yoshihiro Kano
    • Katsuya Ohta
    • Takahito Fukusumi
    • Daisuke Sakai
    • Toshihiro Kudo
    • Naotsugu Haraguchi
    • Taroh Satoh
    • Shuji Takiguchi
    • Masaki Mori
    • Yuichiro Doki
    • Hideshi Ishii
  • View Affiliations

  • Published online on: February 22, 2013     https://doi.org/10.3892/ijo.2013.1837
  • Pages: 1437-1442
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cancer stem cells (CSCs) are known to influence chemoresistance, survival, relapse and metastasis. Aldehyde dehydrogenase (ALDH) functions as an epithelial CSC marker. In the present study, we investigated the involvement of ALDH in gastric CSC maintenance, chemoresistance and survival. Following screening for eight candidate markers (CD13, CD26, CD44, CD90, CD117, CD133, EpCAM and ALDH), five gastric cancer cell lines were found to contain small subpopulations of high ALDH activity (ALDHhigh cells). We also examined the involvement of ALDHhigh cell populations in human primary tumor samples. Immunodeficient NOD/SCID mice were inoculated with tumor tissues obtained from surgical specimens. ALDHhigh cells were found to persist in the xenotransplanted primary tumor samples. in the immunodeficient mice, ALDHhigh cells exhibited a greater sphere‑forming ability in vitro and tumorigenic potential in vivo, compared with subpopulations of low ALDH activity (ALDHlow cells). Cell cultures treated with 5-fluoro­uracil and cisplatin exhibited higher numbers of ALDHhigh cells. Notch1 and Sonic hedgehog (Shh) expression was also found to increase in ALDHhigh cells compared with ALDHlow cells. Therefore, it can be concluded that ALDH generates chemoresistance in gastric cancer cells through Notch1 and Shh signaling, suggesting novel treatment targets.
View Figures
View References

Related Articles

Journal Cover

April 2013
Volume 42 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., Kano, Y., Ohta, K. ... Ishii, H. (2013). Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy. International Journal of Oncology, 42, 1437-1442. https://doi.org/10.3892/ijo.2013.1837
MLA
Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., Kano, Y., Ohta, K., Fukusumi, T., Sakai, D., Kudo, T., Haraguchi, N., Satoh, T., Takiguchi, S., Mori, M., Doki, Y., Ishii, H."Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy". International Journal of Oncology 42.4 (2013): 1437-1442.
Chicago
Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., Kano, Y., Ohta, K., Fukusumi, T., Sakai, D., Kudo, T., Haraguchi, N., Satoh, T., Takiguchi, S., Mori, M., Doki, Y., Ishii, H."Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy". International Journal of Oncology 42, no. 4 (2013): 1437-1442. https://doi.org/10.3892/ijo.2013.1837